Santhera Pharmaceuticals Holding Financial Overview
Santhera Pharmaceuticals Holding's market cap is currently $219.24M. The company's EPS TTM is $-3.8055419199999996; its P/E ratio is -2.24; Santhera Pharmaceuticals Holding is scheduled to report earnings on September 23, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
